Your browser doesn't support javascript.
loading
SLAMF7 (CD319/CS1) is expressed in plasmablastic lymphoma and is a potential diagnostic marker and therapeutic target.
Shi, John; Bodo, Juraj; Zhao, Xiaoxian; Durkin, Lisa; Goyal, Tanu; Meyerson, Howard; Hsi, Eric D.
Affiliation
  • Shi J; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Bodo J; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Zhao X; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Durkin L; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Goyal T; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Meyerson H; Department of Pathology, University Hospitals, Cleveland, OH, USA.
  • Hsi ED; Department of Pathology, University Hospitals, Cleveland, OH, USA.
Br J Haematol ; 185(1): 145-147, 2019 04.
Article in En | MEDLINE | ID: mdl-29785767
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Plasmablastic Lymphoma / Signaling Lymphocytic Activation Molecule Family Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Plasmablastic Lymphoma / Signaling Lymphocytic Activation Molecule Family Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2019 Document type: Article Affiliation country: Country of publication: